Limits...
Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients.

Noh S, Hwang JH, Yoon TH, Chang HJ, Chu IH, Kim JH - Ann Rehabil Med (2015)

Bottom Line: There was no significant difference in the volume reductions between the 3 groups.There were no significant differences in all of the measures between PL and LL.SF-36 scores post-CDT did not differ significantly between AL and LL.

View Article: PubMed Central - PubMed

Affiliation: Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ABSTRACT

Objective: To investigate the changing patterns of edema, quality of life (QOL), and patient-satisfaction after complex decongestive therapy (CDT) in three trajectories: arm lymphedema (AL), secondary leg lymphedema (LL) and primary leg lymphedema (PL).

Methods: Candidates for AL (n=35), LL (n=35) and PL (n=14) were identified from prospective databases. The patients were treated with CDT for 2 weeks, and lymphedema volume was measured before and immediately following the therapy. Patients then self-administered home therapy for 3 months and presented for a follow-up visit. The Korean version of Short Form-36 (SF-36) was used to assess QOL, and we administered a study-specific satisfaction survey.

Results: There was no significant difference in the volume reductions between the 3 groups. There were no significant differences in all of the measures between PL and LL. Overall initial QOL was significantly lower in patients with LL than in patients with AL. SF-36 scores post-CDT did not differ significantly between AL and LL. Clinically significant differences were noted between AL and LL in the mean values of the satisfaction survey.

Conclusion: AL, LL, and PL may have different longitudinal courses. We suggest that lower extremity lymphedema patients present more favorable outcomes after CDT with respect to QOL and satisfaction than upper extremity lymphedema patients. Clinicians should approach patients with different therapeutic considerations specific to each type or region of lymphedema before using CDT in clinical practice.

No MeSH data available.


Related in: MedlinePlus

Changes in limb volume in patients with lymphedema, based on complex decongestive therapy (CDT). PCEV, percent excess volume. ***p<0.001, a)p-values were derived from paired t-tests.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4496505&req=5

Figure 4: Changes in limb volume in patients with lymphedema, based on complex decongestive therapy (CDT). PCEV, percent excess volume. ***p<0.001, a)p-values were derived from paired t-tests.

Mentions: The results of the present study are in close agreement with those of earlier studies that reported significant changes in edema volume and the mental and physical scales of the SF-36 over a 3-month period [5161727]. In all of the groups, the volume reduction primarily occurred within the 2 weeks of treatment, which is similar to previously reported findings [451826]. Further lymphedema volume reductions that were evident at least 12 weeks after treatment were not statistically significant (Fig. 4).


Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients.

Noh S, Hwang JH, Yoon TH, Chang HJ, Chu IH, Kim JH - Ann Rehabil Med (2015)

Changes in limb volume in patients with lymphedema, based on complex decongestive therapy (CDT). PCEV, percent excess volume. ***p<0.001, a)p-values were derived from paired t-tests.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4496505&req=5

Figure 4: Changes in limb volume in patients with lymphedema, based on complex decongestive therapy (CDT). PCEV, percent excess volume. ***p<0.001, a)p-values were derived from paired t-tests.
Mentions: The results of the present study are in close agreement with those of earlier studies that reported significant changes in edema volume and the mental and physical scales of the SF-36 over a 3-month period [5161727]. In all of the groups, the volume reduction primarily occurred within the 2 weeks of treatment, which is similar to previously reported findings [451826]. Further lymphedema volume reductions that were evident at least 12 weeks after treatment were not statistically significant (Fig. 4).

Bottom Line: There was no significant difference in the volume reductions between the 3 groups.There were no significant differences in all of the measures between PL and LL.SF-36 scores post-CDT did not differ significantly between AL and LL.

View Article: PubMed Central - PubMed

Affiliation: Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ABSTRACT

Objective: To investigate the changing patterns of edema, quality of life (QOL), and patient-satisfaction after complex decongestive therapy (CDT) in three trajectories: arm lymphedema (AL), secondary leg lymphedema (LL) and primary leg lymphedema (PL).

Methods: Candidates for AL (n=35), LL (n=35) and PL (n=14) were identified from prospective databases. The patients were treated with CDT for 2 weeks, and lymphedema volume was measured before and immediately following the therapy. Patients then self-administered home therapy for 3 months and presented for a follow-up visit. The Korean version of Short Form-36 (SF-36) was used to assess QOL, and we administered a study-specific satisfaction survey.

Results: There was no significant difference in the volume reductions between the 3 groups. There were no significant differences in all of the measures between PL and LL. Overall initial QOL was significantly lower in patients with LL than in patients with AL. SF-36 scores post-CDT did not differ significantly between AL and LL. Clinically significant differences were noted between AL and LL in the mean values of the satisfaction survey.

Conclusion: AL, LL, and PL may have different longitudinal courses. We suggest that lower extremity lymphedema patients present more favorable outcomes after CDT with respect to QOL and satisfaction than upper extremity lymphedema patients. Clinicians should approach patients with different therapeutic considerations specific to each type or region of lymphedema before using CDT in clinical practice.

No MeSH data available.


Related in: MedlinePlus